| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sayuri Nakamura, Hiroko Sugawara, Ryo Asada, Akito Hatanaka, Hikaru Hor. Bipolar disorder and Lewy body dementia: case report and literature review. Frontiers in psychiatry. vol 15. 2024-06-19. PMID:38895028. |
future research is imperative to identify strategies for preventing dementia in patients with bd and to develop interventions for the comorbidities of bd and dlb. |
2024-06-19 |
2024-06-21 |
Not clear |
| Naoki Saji, Yoshino Kinjo, Kenta Murotani, Shumpei Niida, Akinori Takeda, Takashi Sakura. High pulse wave velocity is associated with enlarged perivascular spaces in dementia with Lewy bodies. Scientific reports. vol 14. issue 1. 2024-06-18. PMID:38886538. |
however, an association between epvs and dementia with lewy bodies (dlb) has not yet been clarified. |
2024-06-18 |
2024-06-21 |
human |
| Tomoki Imokawa, Kota Yokoyama, Kanae Takahashi, Jun Oyama, Junichi Tsuchiya, Nobuo Sanjo, Ukihide Tateish. Brain perfusion SPECT in dementia: what radiologists should know. Japanese journal of radiology. 2024-06-18. PMID:38888851. |
in dementia with lewy bodies (dlb), the differentiating feature is the presence of hypoperfusion in the occipital lobes in addition to that observed in ad. |
2024-06-18 |
2024-06-21 |
Not clear |
| Masha Burelo, Jack Bray, Olga Gulka, Michael Firbank, John-Paul Taylor, Bettina Plat. Advanced qEEG analyses discriminate between dementia subtypes. Journal of neuroscience methods. 2024-06-18. PMID:38889843. |
diagnostic accuracy for dementia subtypes, such as alzheimer's disease (ad), dementia with lewy bodies (dlb) and parkinson's disease with dementia (pdd), remains challenging. |
2024-06-18 |
2024-06-21 |
Not clear |
| Cho Lee, Shang-Hsuan Shih, Yu-Chih She. Successful Use of High-Dose Brexpiprazole for Psychosis in Lewy Body Dementia without Adverse Effects. Psychiatry and clinical psychopharmacology. vol 34. issue 1. 2024-06-17. PMID:38883880. |
we report a 71-year-old patient with a diagnosis of probable dementia with lewy body (dlb) whose psychotic symptoms benefit from a higher dose of brexpiprazole (4 mg per day) without adverse effects. |
2024-06-17 |
2024-06-19 |
Not clear |
| Shunji Toya, Mamoru Hashimoto, Yuta Manabe, Hajime Yamakage, Manabu Iked. Factors Associated with Quality of Life in Patients with Dementia with Lewy Bodies: Additional Analysis of a Cross-Sectional Study. Journal of Alzheimer's disease : JAD. 2024-06-14. PMID:38875033. |
quality of life (qol) and treatment needs of patients with dementia with lewy bodies (dlb) and their caregivers are important factors to consider when developing treatment strategies. |
2024-06-14 |
2024-06-17 |
Not clear |
| Katsuyuki Uka. A proposal for a new concept in psychiatric phenomenology: The "Yume-Utsutsu" (dreamy or half-asleep) phenomenon in patients with dementia with Lewy bodies. PCN reports : psychiatry and clinical neurosciences. vol 1. issue 4. 2024-06-13. PMID:38868649. |
patients with dementia with lewy bodies (dlb) present with a variety of physical and mental symptoms, including visual hallucinations, delusions, depression, rapid eye sleep movement behavior disorder, and olfactory dysfunction. |
2024-06-13 |
2024-06-15 |
Not clear |
| Katsuyoshi Mizukam. Autonomic dysfunction in dementia with Lewy bodies: Focusing on cardiovascular and respiratory dysfunction. PCN reports : psychiatry and clinical neurosciences. vol 2. issue 3. 2024-06-13. PMID:38867816. |
dementia with lewy bodies (dlb) is the second most common cause of dementia after alzheimer's disease. |
2024-06-13 |
2024-06-15 |
Not clear |
| Calum A Hamilton, Paul C Donaghy, Rory Durcan, Joanna Ciafone, Kirsty Olsen, Gemma Roberts, Michael J Firbank, Louise M Allan, John-Paul Taylor, John T O'Brien, Alan J Thoma. Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis. Neurology. vol 103. issue 2. 2024-06-13. PMID:38870460. |
retrospective studies indicate that dementia with lewy bodies (dlb) may be preceded by a mild cognitive impairment (mci) prodrome. |
2024-06-13 |
2024-06-16 |
Not clear |
| Emanuele Camerucci, Aidan F Mullan, Pierpaolo Turcano, Cole D Stang, James Bower, Eduardo E Benarroch, Bradley F Boeve, Rodolfo Savic. A Population-Based Approach to the Argument on Brain-First and Body-First Pathogenesis of Lewy Body Disease. Annals of neurology. 2024-06-11. PMID:38860478. |
to explore the clinical progression of the brain-/body-first categories within lewy body disease (lbd): parkinson's disease (pd), dementia with lewy bodies (dlb), and pd dementia. |
2024-06-11 |
2024-06-14 |
Not clear |
| Tianyu Zheng, David Kotol, Rebecca Sjöberg, Nicholas Mitsios, Mathias Uhlén, Wen Zhong, Fredrik Edfors, Jan Mulde. Characterization of reduced astrocyte creatine kinase levels in Alzheimer's disease. Glia. 2024-06-10. PMID:38856187. |
in our study, cerebral cortex samples from individuals with ad, dementia with lewy bodies (dlb), and age-matched controls were analyzed using antibody-based methods to quantify ckb levels and assess alterations associated with disease processes. |
2024-06-10 |
2024-06-14 |
human |
| Gaku Honda, Shigeki Nagamachi, Mai Takahashi, Yukie Higuma, Tomonobu Tani, Kosuke Hida, Kengo Yoshimitsu, Koji Ogomori, Yoshio Tsubo. The usefulness of combined analysis using CIScore and VSRAD parameters for differentiating between dementia with Lewy body and Alzheimer's disease. Japanese journal of radiology. 2024-06-10. PMID:38856880. |
the cingulate island score (ciscore) is useful index for differentiating between dementia with lewy body (dlb) and alzheimer's disease (ad) using regional cerebral blood flow (rcbf) spect. |
2024-06-10 |
2024-06-14 |
Not clear |
| Bang-Hoon Cho, Hyunsoo Kim, Seong-Min Choi, Soo Hyun Cho, Byeong C Ki. Differences in cognitive trajectories of dementia: Comparison Alzheimer's disease dementia and Dementia with Lewy bodies in Korean patient cohort. Dementia and geriatric cognitive disorders. 2024-06-09. PMID:38852582. |
we aimed to investigate the cognitive trajectories of alzheimer's disease dementia (add) and dementia with lewy bodies (dlb) according to the initial structural change measured by comprehensive visual rating scales (cvrs). |
2024-06-09 |
2024-06-14 |
human |
| Jianing Chi, Jiaman Hu, Ningxia Wu, Hua Cai, Cailong Lin, Yingying Lai, Jianyu Huang, Weihua Li, Peng Su, Min Li, Lin X. Causal effects for neurodegenerative diseases on the risk of myocardial infarction: a two-sample Mendelian randomization study. Aging. vol 16. 2024-06-08. PMID:38850523. |
this study aimed to investigate the potential causal associations of genetically predicted alzheimer's disease (ad), dementia with lewy bodies (dlb), parkinson's disease (pd), and multiple sclerosis (ms) with mi using two-sample mendelian randomization (tsmr). |
2024-06-08 |
2024-06-11 |
Not clear |
| Zhihui Tang, Shigeki Hirano, Yume Koizumi, Michiko Izumi, Yoshihisa Kitayama, Kosuke Yamagishi, Mitsuyoshi Tamura, Ai Ishikawa, Kouichi Kashiwado, Takashi Iimori, Hiroki Mukai, Hajime Yokota, Takuro Horikoshi, Takashi Uno, Satoshi Kuwabar. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies. Journal of Alzheimer's disease : JAD. 2024-06-07. PMID:38848178. |
dementia with lewy bodies (dlb) presents with various symptoms, posing challenges for early diagnosis challenging. |
2024-06-07 |
2024-06-10 |
Not clear |
| Hironobu Endo, Maiko Ono, Yuhei Takado, Kiwamu Matsuoka, Manami Takahashi, Kenji Tagai, Yuko Kataoka, Kosei Hirata, Keisuke Takahata, Chie Seki, Naomi Kokubo, Masayuki Fujinaga, Wakana Mori, Yuji Nagai, Koki Mimura, Katsushi Kumata, Tatsuya Kikuchi, Aki Shimozawa, Sushil K Mishra, Yoshiki Yamaguchi, Hiroshi Shimizu, Akiyoshi Kakita, Hiroyuki Takuwa, Hitoshi Shinotoh, Hitoshi Shimada, Yasuyuki Kimura, Masanori Ichise, Tetsuya Suhara, Takafumi Minamimoto, Naruhiko Sahara, Kazunori Kawamura, Ming-Rong Zhang, Masato Hasegawa, Makoto Higuch. Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases. Neuron. 2024-06-06. PMID:38843838. |
deposition of α-synuclein fibrils is implicated in parkinson's disease (pd) and dementia with lewy bodies (dlb), while in vivo detection of α-synuclein pathologies in these illnesses has been challenging. |
2024-06-06 |
2024-06-10 |
mouse |
| Ryota Kobayashi, Kuniyuki Iwata-Endo, Hiroshige Fujishir. Clinical presentations and diagnostic application of proposed biomarkers in psychiatric-onset prodromal dementia with Lewy bodies. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 2024-06-05. PMID:38837629. |
research criteria for the diagnosis of prodromal dementia with lewy bodies (dlb) include three clinical subtypes: mild cognitive impairment with lewy bodies (mci-lb), delirium-onset prodromal dlb, and psychiatric-onset prodromal dlb. |
2024-06-05 |
2024-06-08 |
Not clear |
| Katharina Bolsewig, Annemartijn A J M van Unnik, Elena R Blujdea, Maria C Gonzalez, Nicholas J Ashton, Dag Aarsland, Henrik Zetterberg, Alessandro Padovani, Laura Bonanni, Brit Mollenhauer, Sebastian Schade, Rik Vandenberghe, Koen Poesen, Milica G Kramberger, Claire Paquet, Olivier Bousiges, Benjamin Cretin, Eline A J Willemse, Charlotte E Teunissen, Afina W Lemstr. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies. Neurology. vol 102. issue 12. 2024-06-03. PMID:38830138. |
plasma β-amyloid-1-42/1-40 (aβ42/40), phosphorylated-tau (p-tau), glial fibrillary acidic protein (gfap), and neurofilament light (nfl) have been widely examined in alzheimer disease (ad), but little is known about their reflection of copathologies, clinical importance, and predictive value in dementia with lewy bodies (dlb). |
2024-06-03 |
2024-06-06 |
Not clear |
| Melissa Scholefield, Stephanie J Church, Jingshu Xu, Stefano Patassini, Garth J S Coope. Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain. Journal of Parkinson's disease. 2024-05-31. PMID:38820022. |
however, no studies have yet been performed to see whether such deficiencies occur across the dementia with lewy bodies (dlb) brain, or what the pattern of such dysregulation may be. |
2024-05-31 |
2024-06-02 |
Not clear |
| Rong Ye, Anna E Goodheart, Joseph J Locascio, Erin Peterec, Michael Properzi, Emma G Thibault, Erin Chuba, Keith A Johnson, Michael J Brickhouse, Alexandra Touroutoglou, John H Growdon, Bradford C Dickerson, Stephen N Gompert. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases. Neurology. vol 102. issue 12. 2024-05-30. PMID:38815233. |
alzheimer disease (ad) copathologies of β-amyloid and tau are common in the lewy body diseases (lbd), dementia with lewy bodies (dlb) and parkinson disease (pd), and target distinct hippocampal subfields compared with lewy pathology, including subiculum and ca1. |
2024-05-30 |
2024-07-16 |
Not clear |